EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interchangeability of Centiloid values from different research and commercial software using [ 18 F]flutemetamol PET images

Ariane Bollack, Christopher Buckley, Mark R Battle, Adam J. Schwarz, Oskar Hansson, Pierrick Bourgeat, Vincent Dore, Jurgen Fripp, Rachid Fahmi, Elena M Bonke, Lennart Thurfjell, William Balhorn und 3 weitere

Alzheimer's & Dementia · 2025-12 · 21 (S2)

DOI: 10.1002/alz70856_106771 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 08.01.2026. Verfasst von Ariane Bollack und 14 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Amyloid PET quantification using the Centiloid (CL) metric is becoming more prevalent and may have a role in clinical decision‐making. But what is the intrinsic confidence interval around a given CL value? To what extent is a CL value from one pipeline equivalent to that from another? We systematically assessed repeatability, reproducibility, and reliability across seven CL quantification pipelines applied to 210 [ 18 F]flutemetamol scans.

Method

Three datasets were used: (1) an AD test‐retest cohort ( N = 10x2); (2) an amnestic MCI cohort ( N = 80); (3) cases from the BioFINDER‐1 cohort enriched for amyloid loads around published positivity thresholds (0‐50CL) ( N = 110). Three regulatory‐approved software (cPET, MIMneuro, syngo . MI Neurology) and four research pipelines (CapAIBL, rPOP, Amypype, SPM8) were evaluated. Dataset 1 was used to assess within‐subject repeatability. Dataset 2 was used to assess reproducibility in terms of absolute agreement in continuous CL values. Datasets 2 and 3 were used to assess reliability for dichotomizing amyloid scans into positive and negative. The latter was performed for three thresholds of 11, 25 and 37 CL.

Result

The test‐retest analysis revealed absolute biases 92% for scans across a wide range of CL values, but the percentage was lower for scans with amyloid loads closer to the range of typical positivity thresholds. Uncertainty estimates should always be considered when interpreting results.

Zitieren

APA

Bollack, A., Buckley, C., Battle, M. R., Schwarz, A. J., Hansson, O., Bourgeat, P., Dore, V., Fripp, J., Fahmi, R., Bonke, E. M., Thurfjell, L., Balhorn, W., Haas, M., Page, C., & Farrar, G. (2025). Interchangeability of Centiloid values from different research and commercial software using [ 18 F]flutemetamol PET images. Alzheimer's & Dementia, 21(S2). https://doi.org/10.1002/alz70856_106771

Vancouver

Bollack A, Buckley C, Battle MR, Schwarz AJ, Hansson O, Bourgeat P, et al. Interchangeability of Centiloid values from different research and commercial software using [ 18 F]flutemetamol PET images. Alzheimer's & Dementia. 2025;21(S2). doi:10.1002/alz70856_106771

BibTeX
@article{Bollack2025,
  author = {Bollack, Ariane and Buckley, Christopher and Battle, Mark R and Schwarz, Adam J. and Hansson, Oskar and Bourgeat, Pierrick and Dore, Vincent and Fripp, Jurgen and Fahmi, Rachid and Bonke, Elena M and Thurfjell, Lennart and Balhorn, William and Haas, Mike and Page, Christopher and Farrar, Gill},
  title = {Interchangeability of Centiloid values from different research and commercial software using [ 18 F]flutemetamol PET images},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {S2},
  doi = {10.1002/alz70856_106771}
}
Kostenlos starten →